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The Cholinergic System and Inflammation: Common Pathways
in Delirium Pathophysiology
Joaquim Cerejeira, MD,*† Vasco Nogueira, MD,*† Pedro Luı´s, MD,* Adriano Vaz-Serra, PhD,† and
Elizabeta B. Mukaetova-Ladinska, MD, PhD‡
OBJECTIVES: To investigate whether delirium is associ-
ated with an unbalanced inflammatory response or a dys-
functional interaction between the cholinergic and immune
systems.
DESIGN: Cohort observational study.
SETTING: General hospital orthopedic ward.
PARTICIPANTS: One hundred one individuals aged 60
and older with no previous cognitive impairment under-
going elective arthroplasty.
MEASUREMENTS: Incidence of postoperative delirium,
plasma cholinesterase activity (acetylcholinesterase (AChE)
and butyrylcholinesterase (BuChE)) and inflammatory
mediators (C-reactive protein (CRP), interleukin (IL)-1
beta, tumor necrosis factor alpha, IL-6, IL-8, IL-10) before
and after surgery.
RESULTS: Thirty-seven participants developed postopera-
tive delirium and had greater production of CRP and pro-
inflammatory to anti-inflammatory ratio after surgery. In
participants with delirium, but not in controls, preopera-
tive levels of plasma cholinesterase activity correlated with
DCRP (AChE: ρ = 0.428, P = .008 and BuChE: ρ = 0.423,
P = .009), DIL-6 (AChE: ρ = 0.339, P = .04), and DP/A
ratio (AChE: ρ = 0.346, P = .04).
CONCLUSION: Delirium was associated not only with
an unbalanced inflammatory response, but also with a dys-
functional interaction between the cholinergic and immune
systems. Comprehensive understanding of the relationship
between the cholinergic and immune systems is crucial to
developing new insights into delirium pathophysiology and
novel therapeutic interventions. J Am Geriatr Soc 2012.
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Delirium is a common neuropsychiatric syndrome char-acterized by sudden onset of impaired consciousness
and inattention with subsequent cognitive and behavioral
disturbance.1 From a pathophysiological perspective, this
syndrome can be best conceptualized as a dysfunction in
the homeostatic response to a precipitating factor (e.g.,
medical or surgical condition) resulting in an acute failure
of the central nervous system (CNS). The two dominant
theories regarding delirium pathophysiology are choliner-
gic deficiency and aberrant stress response and neuroin-
flammation.2
Surgery (e.g., hip arthroplasty) is a controlled trau-
matic event that directly induces tissue ischemia and
destruction amid a diversity of factors such as hypoten-
sion, hypoxia, pain, blood loss, anesthetics, and drugs.
Globally, the effect of these factors on the body elicits a
number of intricate physiological responses characterized
by the production and release of proinflammatory cyto-
kines into the bloodstream, activation of the inflammatory
cascade, and recruitment of immune cells. Protective
immunity is critically dependent on adequate balance
between pro- and anti-inflammatory responses to allow
proper repair of tissue damage and to combat overwhelm-
ing infection without compromising organ function. Thus,
counterregulatory mechanisms are simultaneously activated
to inhibit the systemic innate immune response. These
consist of anti-inflammatory cytokines (e.g., interleukin
(IL)-10), stress hormones, and signals originating from
the CNS culminating in the release of acetylcholine by the
vagus nerve, which interacts with nicotine acetylcholine
receptors in immune cells.3 Disruption of these complex
homeostatic mechanisms may be involved in delirium
pathophysiology as increased secretion of proinflammatory
cytokines into the bloodstream triggers an exaggerated
neuroinflammatory reaction, affecting synaptic and neuro-
nal function and coupled with cognitive and behavioral
symptoms similar to delirium.2
The few clinical studies conducted so far exploring the
inflammatory response in delirium have provided contra-
dictory results. Although high levels of C-reactive protein
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(CRP) have been associated with delirium in medical4–6
and surgical6 patients, other studies have not supported
these findings.7–11 Likewise, negative findings8–10,12–14
have followed positive associations between delirium and
higher plasma levels of IL-6,4–6 IL-8,12,15 and IL-10.7 High
serum cytokines have also been found in sickness behavior
independently of delirium occurrence (e.g., IL-6 and
TNF-a)16 or postoperatively in individuals with impaired
cognition.17
Thus, the relationship between the absolute levels of
serum inflammatory mediators and delirium is inconsis-
tent, heterogeneous, and difficult to generalize, compromis-
ing their clinical utility as biomarkers for this clinical
syndrome. This also confirms that we are far from under-
standing to what extent the presence of inflammatory
mediators in the bloodstream contributes to the develop-
ment of neuropsychiatric symptoms leading to delirium.
Additionally, although the cholinergic antiinflammatory
pathway has been well characterized in animal models18
and implicated in inflammatory and infectious disorders,3
there is a lack of studies analyzing the interconnection
between the cholinergic system and the innate immune
response in individuals with delirium. A recent study dem-
onstrated that individuals who develop postoperative delir-
ium have substantially lower plasma cholinesterase activity
before surgery, suggesting that an altered cholinergic func-
tion in resting conditions is a risk marker of delirium.19
The current study built on these findings and sought
to clarify whether delirium is associated with an unbal-
anced inflammatory response or a dysfunctional interac-
tion between the cholinergic and immune systems. It
specifically addressed whether individuals with delirium
would have an imbalance of proinflammatory to antiin-
flammatory cytokine concentration before or after surgery
and a dysfunction in baseline plasma cholinesterases activ-




The study included consecutive individuals aged 60 and
older undergoing elective total hip arthroplasty and not
fulfilling the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Text Revision, (DSM-IV-TR)
criteria for dementia or delirium at the time of their preop-
erative medical evaluation, which included collection of
demographic and clinical data and an assessment using the
Charlson Comorbidity Index, Barthel Index, Mini-Mental
State Examination (MMSE), and 15-item Geriatric Depres-
sion Scale.
Medical and Surgical Procedures and Perioperative
Factors
Nonsteroidal anti-inflammatory and antiplatelet drugs
were discontinued for at least 1 week before surgery, and
thromboprophylaxis (subcutaneous low-molecular-weight
heparin) was administered to each participant daily during
that week until the day before surgery, with prophylactic
intravenous antibiotherapy being initiated on the day of
surgery. General anesthesia was induced with propofol,
and after the administration of a muscular relaxant,
patients were intubated and mechanically ventilated. Alter-
natively, regional anesthesia (administration of analgesic
medication (e.g., levobupivacaine) into the subarachnoid
space through a catheter) was used. All patients were mon-
itored during surgery, with fluid loss being replaced using
an intravenous crystalloid solution and, if necessary, trans-
fusion of red blood cells or whole blood. A lateral surgical
approach with trochanteric osteotomy was used for the
arthroplasty.
Postoperative Assessment
After surgery, all participants were assessed for delirium
using the Confusion Assessment Method (CAM) (per-
formed by a trained psychiatrist) on 3 consecutive days
between 6 and 8 p.m. The first assessment occurred on the
evening of the surgery day and the second and third took
place on postoperative days 2 and 3. The CAM was rated
during a brief interview with the participant that also
included the MMSE. Positive cases of delirium (according
to the CAM criteria) were confirmed according to the
DSM-IV-TR criteria. The final sample consisted of 101
participants, 37 of whom developed delirium during the
study period. Participants with delirium did not differ from
those without on any preoperative or perioperative vari-
able, except that they were less likely to consume alcohol
regularly (Table 1).
Measurements of Serum Cholinesterase Catalytic
Activities
Venous blood samples were collected from each partici-
pant in the morning of the day before surgery and in the
morning of the first postoperative day. Plasma was imme-
diately separated by centrifugation and stored at –80°C
until analysis. Plasma acetylcholinesterase (AChE) and bu-
tyrylcholinesterase (BuChE) activity was assayed by mea-
suring the production of thiocholine from the hydrolysis of
the respective specific substrates acetylthiocholine iodide
and S-butyrylthiocholine iodide. The production of 5-thio-
2-nitrobenzoate was monitored using a Cary 100 Spectro-
photometer (Varian, Cary, NC) at 412 nm over time
(every minute for 8 minutes). Enzyme activity is expressed
as lmol of 5,5′-dithiobis-(2-nitrobenzoic acid) transformed
per mL of plasma per minute.19
Measurement of Inflammatory Mediators
The concentrations of five cytokines (IL-8, IL-1 beta (b),
IL-6, IL-10, tumor necrosis factor alpha (TNF-a)) and
CRP were determined using the xMAP Bio-Plex Suspen-
sion Array System 200 with multiplex assay kits purchased
from Bio-Rad (Hercules, CA) and Invitrogen (Carlsbad,
CA). Standard curves were constructed for determination
of each analyte concentration according to the manufac-
turers’ instructions. The detection limits of the assays were
0.002 ng/mL for CRP, 0.8 pg/mL for IL-1b, 3 pg/mL for
TNF-a, 1.1 pg/mL for IL-6, 0.5 pg/mL for IL-8, and
0.9 pg/mL for IL-10. In accordance with standard practice,
samples with undetectable cytokine levels were entered at
half of the minimum detection level derived from the
2 CEREJEIRA ET AL. 2012 JAGS
standard curve. Because IL-10 could be measured in all
samples, plasma levels of each cytokine were used to cal-
culate the proinflammatory to anti-inflammatory ratio (P/
A) according to the formula (IL–1b + TNF-a + IL-6 + IL-
8)/ IL-10.
Statistical Analysis
Data were analyzed using the SPSS, version 17.0.2
(PASW Statistics 17, SPSS, Inc., Chicago, IL). The signifi-
cance of the difference between the pre- and postopera-
tive levels of each biomarker was determined using the
Student t-test for paired samples or the Wilcoxon test as
a nonparametric alternative. Comparison between partici-
pants with and without delirium for pre and postopera-
tive values was performed using the Student t-test for
independent samples (normal distributions) or the Mann
Whitney U-test (non-normal distributions). The Pearson
chi-square test was used to analyze the relationship
between categorical variables. The association between
preoperative cholinesterase activity and the difference
between the two determinations within participants (end-
point – baseline levels, D) for each inflammatory marker
was assessed using the Spearman correlation coefficient.




Although surgery induced an overall reduction in AChE
and BuChE plasma activity in the control and delirium
groups, participants who developed delirium had substan-
tially lower levels of plasma esterase activity before surgery
than controls (Table 2).





(n = 37) No Delirium (n = 64) P-Value
Male, n (%) 50 (49.5) 15 (40.5) 35 (54.7) .22*
Age, mean ± SD (range) 73 ± 6.3 (60–89) 73.6 ± 5.9 (64–89) 72.7 ± 6.5 (60–87) .46†
Education, years, n (%)
0 20 (19.8) 8 (21.6) 12 (18.7) .85*
1–4 69 (68.3) 24 (64.9) 45 (70.3)
 5 12 (9.9) 5 (13.5) 7 (10.9)
Smoking, n (%)
No smoking 82 (81.2) 30 (81.1) 52 (81.3) >.99*
Past or active smoking 19 (18.8) 7 (18.9) 12 (18.7)
Alcohol, n (%)
No active drinking 46 (45.5) 24 (64.9) 22 (34.4) .004*
Active drinking 55 (54.5) 13 (35.1) 42 (65.6)
Charlson Comorbidity Index, mean ± SD
(range)
0.5 ± 0.7 (0–4) 0.7 ± 0.9 (0–4) 0.5 ± 0.6 (0–3) .36‡
Mini-Mental State Examination score,
mean ± SD (range)
26.7 ± 2.8 (19–30) 26.4 ± 2.8 (19–30) 26.8 ± 2.8 (19–30) .38‡
Barthel Index, mean ± SD (range) 91.0 ± 12.6 (45–100) 88.5 ± 14.3 (50–100) 92.4 ± 11.3 (45–100) .15‡
Geriatric Depression Scale, mean ± SD (range) 4.5 ± 3.2 (0–12) 4.6 ± 3 (0–12) 4.4 ± 3.2 (0–12) .55‡
Number of different medications taken
by the participant outside the hospital during
the week before the surgery and administered
in the hospital until the day before
surgery, mean ± SD (range)
3.4 ± 2.4 (0–9) 4.0 ± 2.8 (0–9) 3.0 ± 2.1 (0–9) .11‡
Anticholinergic activity of administrated
medications in the week before surgery as
determined by the Anti-cholinergic Drug
Scale,20 mean ± SD (range)
0.7 ± 1.1 (0–5) 0.8 ± 1.3 (0–5) 0.6 ± 0.7 (0–3) .7 ‡
General anesthesia, n (%) 68 (67.3) 29 (78.4) 39 (60.9) .08*
Perioperative transfusion, n (%) 31 (30.7) 15 (40.5) 16 (25) .08*
* Chi-square test.
† Student t-test.
‡ Mann Whitney test.
SD = standard deviation.
















Delirium 2.42 ± 0.57 .01 1.88 ± 0.46 .09 <.001
No delirium 2.71 ± 0.51 2.04 ± 0.45 <.001
Butyrylcholinesterase
Delirium 4.79 ± 1.28 .04 3.24 ± 0.74 .03 <.001
No delirium 5.33 ± 1.21 3.61 ± 0.84 <.001
* Student t-test for independent samples.
† Student t-test for paired samples.
SD = standard deviation.
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Plasma Levels of Inflammatory Mediators
Preoperative levels of CRP, IL-1b, and TNF-a were below
the detection level in 8%, 21%, and 27% of participants,
respectively. All participants who developed delirium pre-
sented preoperatively with detectable levels of CRP
(0.002 ng/mL), whereas this marker was measurable in
87.5% of the remaining participants (P = .02). In the post-
operative sample, CRP, IL-1b, TNF-a, and IL-6 were not
measurable in 4%, 28%, 44%, and 3% of participants,
respectively. These percentages were similar in participants
with and without delirium. The proportion of participants
with CRP of 5 ng/mL or greater (a cutoff value used in
clinical practice) was similar between the groups with and
without delirium before surgery (10.8% vs 7.8%, P = .72)
and on the first postoperative day (78.4% vs 81.2%,
P = .80).
No differences were observed between the two groups
regarding plasma levels of each mediator pre- or postoper-
atively (Table 3). Participants with delirium had a signifi-
cantly higher P/A ratio on the first postoperative day
(Table 3).
Correlation Between Baseline Cholinesterase Activity
and Magnitude of Inflammatory Reaction (D)
Plasma activity of AChE and BuChE before surgery corre-
lated with DCRP in participants who developed delirium
(ρ = 0.428, P = .008, and ρ = 0.423, P = .009; Figure 1A
and B, respectively) but not in controls (ρ = 0.057, P = .65
and ρ = 0.085, P = .50). Similarly, AChE activity corre-
lated with DIL-6 (ρ = 0.339, P = .04; Figure 1C) and with
DP/A ratio (ρ = 0.346, P = .04, Figure 1D) in participants
with delirium but not in those who did not developed
delirium (ρ= 0.028, P = .82 and ρ = 0.207, P = .10,
respectively). No correlations were found between baseline
plasma cholinesterase activity and within-individual differ-
ence in each inflammatory mediator (data not shown).
DISCUSSION
It has been proposed that central cholinergic dysfunction
and a deregulated neuroinflammatory reaction in response
to systemic inflammation may be involved in delirium
pathophysiology.2,21 In addition, the CNS modulates the
innate immune response through the cholinergic output
of the vagus nerve.3 It has recently been reported that
individuals with delirium had lower plasma levels of
cholinesterase activity than controls even before surgery,
suggesting that lower plasma levels of cholinesterase
activity may precede and even contribute to the develop-
ment of an acute confusional state.19
The current study demonstrated that, when people
were challenged with surgical trauma, production of CRP
was significantly higher and that a shift toward a
proinflammatory response (as shown by a greater P/A
ratio) was observed in patients with delirium. This
suggests that an imbalance between proinflammatory and
antiinflammatory factors, in favor of a proinflammatory
response, might be involved in delirium. Conversely, in
agreement with several studies7–14 none of the plasma lev-
els of each inflammatory marker measured in this study
were related to delirium.
Although these findings are discordant with previous
reports of a possible association between inflammatory
Table 3. Plasma Levels of Inflammatory Markers Before and After Surgery and within (Pre- and Postoperative)
and Between (Delirium vs No Delirium) Groups
Inflammatory Marker
Preoperative Postoperative
P-Value†Median (IQR) P-Value* Median (IQR) P-Value*
C-reactive protein
Delirium 0.38 (1.17) .86 18.31 (11.82) .67 <.001
No delirium 0.51 (0.91) 15.89 (15.31) <.001
IL-1b
Delirium 0.40 (0.55) .57 0.4 (0.39) .86 .90
No delirium 0.46 (0.61) 0.4 (0.38) .05
Tumor necrosis factor alpha
Delirium 6.12 (9.28) .54 1.5 (5.01) .98 .50
No delirium 6.2 (9.96) 1.5 (8.3) .22
IL-6
Delirium 7.95 (8.59) .65 117.39 (148.07) .14 <.001
No delirium 8.27 (8.49) 93.18 (99.25) <.001
IL-8
Delirium 9.16 (7.02) .56 18.83 (17.3) .14 <.001
No delirium 8.6 (6.51) 16.59 (11.25) <.001
IL-10
Delirium 1.81 (1.64) .10 3.17 (3.23) .97 <.001
No delirium 2 (1.37) 3.18 (3.85) <.001
Pro-/anti-inflammatory ratio
Delirium 12.44 (9.61) .18 38.06 (27.13) .049 <.001
No delirium 11.14 (5.71) 28.31 (26) <.001
* Mann Whitney test.
† Wilcoxon test.
IL = interleukin.
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markers and delirium4–7,12,15 it is likely that isolated levels
of cytokines in the bloodstream do not accurately capture
the complex homeostatic dysfunction occurring during a
delirium episode. This is not surprising, considering that
cytokines have pleiotropic and redundant functions within
a complex network of various interactions between
them.22 Consequently, the organism response to acute
release of inflammatory mediators into the bloodstream
depends more on the integrated actions of overlapping
intracellular signaling pathways shared by different patho-
physiological routes than on the level of a particular cyto-
kine. P/A ratios might be a more valuable index of the
association between systemic cytokine response and rele-
vant clinical outcomes not only in coronary syndromes23,24
and sepsis,25,26 but also in delirium, as the current results
suggest.
A dynamic and intricate cross-talk with the central
nervous system and neuroendocrine systems tightly modu-
lates immune system actions, including cytokine produc-
tion and effects.27 In particular, the inhibitory control of
the cholinergic anti-inflammatory pathway on the innate
immune response is a recently described homeostatic
mechanism maintaining proinflammatory responses within
an adequate range.3 In response to systemic inflamma-
tion, the CNS stimulates vagus nerve outflow with the
release of acetylcholine. Through inhibition of nuclear
factor kappa B nuclear translocation and activation of
janus kinase signal transducer and activator of transcrip-
tion pathways, acetylcholine attenuates the production of
TNF, IL-1b, IL-6, and IL-18 immune cells expressing the
nicotinic acetylcholine receptor subunit a7.18 Under rest-
ing conditions, the set point of this reflex arch contrib-
utes to establishing the magnitude of the innate
inflammatory response to surgical trauma.3 Plasma cho-
linesterase activity, resulting from the conjoined action of
peripheral AChE and BuChE, is responsible for the
hydrolysis of acetylcholine, thus regulating peripheral
cholinergic signaling.
A positive correlation was found between baseline
plasma cholinesterase activity and high CRP, IL-6, and
(A) (B)
(C) (D)
Figure 1. Scatter plots and Spearman correlation coefficients of significant association between preoperative plasma cholinester-
ase activity and inflammatory markers in participants who developed delirium ( ) and controls (○- - -). D = end point minus
baseline levels; P/A = proinflammatory/anti-inflammatory ratio.
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P/A ratio after surgery in participants with delirium but
not in controls. Thus, overactivity of the relationship
between cholinergic and inflammatory systems emerges as
a common feature in the participants with delirium, in
whom exposure to surgery induced different degrees of
inflammation according to baseline status of the peripheral
cholinergic system (Figure 2). In contrast, the inflamma-
tory response after surgery was independent of baseline
cholinesterase activity in participants without delirium. It is
plausible that a hyperactive cholinergic anti-inflammatory
pathway may underlie the greater strength of correlation
between plasma cholinesterase activity and the levels of
inflammatory markers observed in individuals with delir-
ium. The lack of correlation in the control group indicates
a weaker relationship between the cholinergic and immune
systems and the contribution of other factors, not
addressed in this study, maintaining the inflammatory
response tightly regulated. The detailed mechanisms by
which the responsiveness of the cholinergic antiinflamma-
tory pathway is regulated remain unclear. Recent evidence
suggests that vagal reactivity and cholinesterase activity
depend on the constitutive expression of acetylcholine
receptors at the peripheral organs.28
The results of the current study indicate that plasma
cholinesterase activity can be a candidate biomarker of the
inhibitory cholinergic tone at the periphery. When consid-
ering the group of participants with delirium, higher base-
line cholinesterase activity was associated with heightened
proinflammatory response, whereas participants with
lower cholinesterase activity before surgery had a lower
proinflammatory reaction. A definite conclusion cannot be
reached about how AChE and BuChE activity levels corre-
late with peripheral levels of acetylcholine or with the
responsiveness of vagal nerve to inflammation, but a dose-
dependent positive correlation between cholinesterase
activity and peripheral cytokine response to immune chal-
lenge, largely mediated by the vagus nerve, has been dem-
onstrated.29,30 Also, the rate of acetylcholine degradation
in peripheral organs critically determines the physiological
effects of vagus nerve activity.31,32 It is therefore conceiv-
able that lower plasma AChE and BuChE levels are associ-
ated with a greater supply of acetylcholine for ligation
with cholinergic receptors in immune cells downregulating
inflammation (Figure 2). This provides insight into the
potential reasons for failure in previous attempts to modu-
late the cholinergic and inflammatory imbalance through
administration of AChE inhibitors. Thus, in a recent ran-
domized controlled trial, critically ill patients with delir-
ium receiving a cholinesterase inhibitor (rivastigmine) had
greater mortality than participants not treated with this
drug.33 Alternatively, recent experimental evidence shows
that administration of AChE inhibitors suppresses systemic
inflammation and enhances survival of animals exposed to
lipopolysaccharides29,30 or infection.34 These conflicting
results demonstrate that any modulation of the cholinergic
system should take into account the complex regulatory
mechanisms determining the participant’s baseline immune
set point and the magnitude of responsiveness to inflam-
matory challenge.
An obvious strength of this study is the use of a prospec-
tive design in which several markers were simultaneously
measured before and after a controlled traumatic event (hip
arthroplasty) in a well-characterized sample of participants
with no prior cognitive impairment, although this limits the
generalization of the results to clinical samples more likely
to benefit from interventions to prevent and treat delirium.
The technology used in this study (multiplex arrays) has a
number of advantages over traditional enzyme-linked
immunosorbent assay (ELISA), offering the possibility of
analyzing a panel of cytokines in a cost-effective fashion.
Nevertheless, although some studies in delirium have used
multiplex technology,8,12,14,15 experience with this method
Figure 2. Relationship between the cholinergic and inflammatory systems in delirium. At the periphery, the cholinergic
anti-inflammatory pathway modulates the immune system through the interaction of acetylcholine (ACh) with immune cells.
In baseline conditions, acetylcholine availability depends on vagus nerve output and its degradation by cholinesterases (ChE).
In patients with delirium, exposure to surgical trauma induced different degrees of inflammation according to the baseline status
of the peripheral ChE activity, suggesting that delirium is associated with an overactive relation between cholinergic and inflam-
matory systems.
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remains limited, and comparisons with prior studies using
ELISA should be made cautiously because concordance
between the two methods has not been definitively
established.35 Although the assay used in the current study
provides a lower limit of detection of IL-1b than previous
studies, the levels of this cytokine, as in the case of TNF-a,
were undetectable in a significant proportion of samples,
and no changes were observed after surgery, confirming that
these potent proinflammatory cytokines, which have brief
half-lives in circulation, are unlikely to be useful markers of
acute injury or illness.36 Because the postoperative blood
draw and the clinical assessment of delirium were not coin-
cident in time, the observed changes in postoperative cyto-
kine levels may not reflect the status of the immune system
during the delirium episode.
In conclusion, delirium is associated with an inflam-
matory imbalance favoring the production of proinflam-
matory cytokines. Furthermore, changes in the cholinergic
system, observed preoperatively, predicted the magnitude
of the inflammatory response to surgical trauma. Thus,
this study strengthens the view that a comprehensive
understanding of the relationship between the cholinergic
and immune systems is crucial to yielding new insights
into delirium pathophysiology.
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